A securities class action has been filed in the USDC — E.D.TX. against Orthofix Medical Inc. (OFIX) (“Orthofix” or the “Company”), on behalf of all persons or entities that purchased or otherwise acquired Orthofix common stock between October 11, 2022 and September 12, 2023, both dates inclusive (the “Class Period”).

The complaint alleges that throughout the Class Period, Defendants issued false and misleading statements and/or failed to disclose adverse facts about the Company’s management team. When the truth about the Company’s management team was revealed, the price of Orthofix common stock suffered sharp declines. As a result, Plaintiff and other Class members have suffered significant losses and damages.

On this news, the Company’s stock declined $5.62 per share, or over 30%, to close at $13.01 per share on September 13, 2023, on unusually heavy volume.

If you purchased Orthofix common stock during the class period and would like to receive more information or join the action, please enter your contact information below for a FREE consultation and click “Submit Your Information”.

About Lowey Dannenberg

Lowey Dannenberg is a national firm representing institutional and individual investors, who suffered financial losses resulting from corporate fraud and malfeasance in violation of federal securities and antitrust laws. The firm has significant experience in prosecuting multi-million-dollar lawsuits and has previously recovered billions of dollars on behalf of investors.